Does SUNITINIB Cause Neoplasm progression? 48 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Neoplasm progression have been filed in association with SUNITINIB. This represents 2.7% of all adverse event reports for SUNITINIB.
48
Reports of Neoplasm progression with SUNITINIB
2.7%
of all SUNITINIB reports
10
Deaths
7
Hospitalizations
How Dangerous Is Neoplasm progression From SUNITINIB?
Of the 48 reports, 10 (20.8%) resulted in death, 7 (14.6%) required hospitalization, and 1 (2.1%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SUNITINIB. However, 48 reports have been filed with the FAERS database.
What Other Side Effects Does SUNITINIB Cause?
Disease progression (280)
Drug ineffective (243)
Malignant neoplasm progression (242)
Fatigue (132)
Diarrhoea (129)
Osteonecrosis of jaw (115)
Hypertension (99)
Off label use (99)
Thrombocytopenia (96)
Death (85)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which SUNITINIB Alternatives Have Lower Neoplasm progression Risk?
SUNITINIB vs SUNITINIB MALATE
SUNITINIB vs SUTENT
SUNITINIB vs SUTIMLIMAB-JOME
SUNITINIB vs SUVOREXANT
SUNITINIB vs SUZETRIGINE